EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer

Somayeh Hashemi Sheikhshabani, Paratoo Modarres, Soudeh Ghafouri-Fard iD, Zeinab Amini-Farsani, Lavin Khodaee, Nasibeh Shaygan, Zahra Amini-Farsani, Mir Davood Omrani iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.1970 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Reports, 2024. Verfasst von Somayeh Hashemi Sheikhshabani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Student Research Committee, Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is a major cause of cancer‐related mortality worldwide, with a 5‐year survival rate of approximately 22%. Cisplatin is one of the standard first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC), but its efficacy is often limited by the development of resistance. Despite extensive research on the molecular mechanisms of chemoresistance, the underlying causes remain elusive and complex.

Aims

We analyzed three microarray datasets to find the gene signature and key pathways related to cisplatin resistance in NSCLC. Methods and Results We compared the gene expression of sensitive and resistant NSCLC cell lines treated with cisplatin. We found 274 DEGs, including 111 upregulated and 163 downregulated genes, in the resistant group. Gene set enrichment analysis showed the potential roles of several DEGs, such as TUBB2B , MAPK7 , TUBAL3 , MAP2K5 , SMUG1 , NTHL1 , PARP3 , NTRK1 , G6PD , PDK1 , HEY1 , YTHDF2 , CD274 , and MAGEA1 , in cisplatin resistance. Functional analysis revealed the involvement of pathways, such as gap junction, base excision repair, central carbon metabolism, and Notch signaling in the resistant cell lines.

Conclusion

We identified several molecular factors that contribute to cisplatin resistance in NSCLC cell lines, involving genes and pathways that regulate gap junction communication, DNA damage repair, ROS balance, EMT induction, and stemness maintenance. These genes and pathways could be targets for future studies to overcome cisplatin resistance in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansCisplatinDrug Resistance, NeoplasmSignal Transduction

Stichwörter der Autor:innen

BEREMTPARP3cisplatin resistancemicroarraynon-small cell lung cancer

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Cell and Molecular Biology and Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, Iran.
  • Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Biotechnology and Plant Breeding, Islamic Azad University Science and Research Branch, Tehran, Iran.
  • Bayesian Imaging and Spatial Statistics Group, Institute of Statistics, Ludwig-Maximilian-Universität München, Munich, Germany.
  • Department of Statistics, Lorestan University, Khorramabad, Iran.

ORCID-Profile: Soudeh Ghafouri-Fard, Mir Davood Omrani

Förderung

  • Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Student Research Committee, Tabriz University of Medical Sciences

Zitieren

APA

Sheikhshabani, S. H., Modarres, P., Ghafouri-Fard, S., Amini-Farsani, Z., Khodaee, L., Shaygan, N., Amini-Farsani, Z., & Omrani, M. D. (2024). Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer. Cancer Reports. https://doi.org/10.1002/cnr2.1970

Vancouver

Sheikhshabani SH, Modarres P, Ghafouri-Fard S, Amini-Farsani Z, Khodaee L, Shaygan N, et al. Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer. Cancer Reports. 2024. doi:10.1002/cnr2.1970

BibTeX
@article{Sheikhshabani2024,
  author = {Sheikhshabani, Somayeh Hashemi and Modarres, Paratoo and Ghafouri-Fard, Soudeh and Amini-Farsani, Zeinab and Khodaee, Lavin and Shaygan, Nasibeh and Amini-Farsani, Zahra and Omrani, Mir Davood},
  title = {Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.1970}
}
Kostenlos starten →